<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6755163/results/search/test_trace/results.xml">
  <result pre="hepatocytes are a valuable tool for investigating hepatitis B virus" exact="infection" post="and antiviral drugs ZhouMing12*QinBo3*DengXue-Song4ZengXiao-Li5LuYing1HuangZi-Gang2WuChun-Chen6MouLi-Sha1[1], [2], [3], [4], [5], [6],"/>
  <result pre="are the ‘gold standard’ for investigating hepatitis B virus (HBV)" exact="infection" post="and antiviral drugs. However, poor availability, variation between batches"/>
  <result pre="isolated and infected with hNTCP-recombinant lentivirus, and susceptibility to HBV" exact="infection" post="in the two cell types was tested and compared."/>
  <result pre="two cell types was tested and compared. In addition, HBV" exact="infection" post="efficiency of hNTCP-expressing PPHs with pooled HBV-positive serum and"/>
  <result pre="determined. The potential use of HBV-infected hNTCP-expressing PPHs for drug" exact="screening" post="was assessed. The results demonstrated that pigs and rabbits"/>
  <result pre="formation and infectious particle secretion. hNTCP-expressing PPHs were susceptible to" exact="infection" post="with HBV particles purified from pooled HBV-positive sera, but"/>
  <result pre="The use of HBV-infected hNTCP-expressing PPHs for viral entry inhibitor" exact="screening" post="was revealed to be applicable and reproducible. In conclusion,"/>
  <result pre="conclusion, hNTCP-expressing PPHs may be valuable tool for investigating HBV" exact="infection" post="and antiviral drugs. hepatitis B virus sodium taurocholate co-transporting"/>
  <result pre="primary pig hepatocyte cell model Introduction Hepatitis B virus (HBV)" exact="infection" post="exhibits a wide spectrum of clinical liver manifestations (1)."/>
  <result pre="to be the ‘gold standard’ cell model for studying HBV" exact="infection" post="(2). However, poor availability, variation between batches and ethical"/>
  <result pre="are less expensive, but also difficult to obtain, and HBV" exact="infection" post="of PTHs is different compared with that of PHHs,"/>
  <result pre="of dimethyl sulfoxide (DMSO) plus polyethylene glycol 8000 (PEG8000) during" exact="infection" post="does not significantly promote HBV infectivity (3). The discovery"/>
  <result pre="hepatocytes with hNTCP does not result in susceptibility to HBV" exact="infection" post="(4–6), which indicates that additional host factors may be"/>
  <result pre="to HBV infection, whereas mouse and rat hepatocytes resist HBV" exact="infection" post="(4–6). In the present study, it was presumed that"/>
  <result pre="generation of an easily obtained primary cell model for HBV" exact="infection" post="based on other laboratory animals may be valuable for"/>
  <result pre="laboratory animals may be valuable for fundamental research on HBV" exact="infection" post="and antiviral drugs. To achieve this goal, evolutionary distance"/>
  <result pre="also screened in the hNTCP-complemented hepatocytes. Materials and methods Cell" exact="isolation" post="and culture Ethical approval for the study was granted"/>
  <result pre="8.4×108 HBV copies/ml, as measured by quantitative PCR (qPCR). HBV" exact="infection" post="PPHs and PRHs were seeded and maintained at 100%"/>
  <result pre="was added directly to the cells with a multiplicity of" exact="infection" post="(MOI) of 1,000. For HBV infection with purified patient"/>
  <result pre="with a multiplicity of infection (MOI) of 1,000. For HBV" exact="infection" post="with purified patient serum, a MOI of 200 was"/>
  <result pre="the medium was changed every 2 days. For the competing" exact="infection" post="assays, the cells were pre-incubated with different concentrations of"/>
  <result pre="and infectious medium containing myr-preS12-47 was added. For the blocking" exact="infection" post="assays, infectious media were pre-incubated with different concentrations of"/>
  <result pre="sapiens and M. mulatta in the divergence tree for the" exact="isolation" post="of primary hepatocytes may facilitate the HBV post-entry lifecycle."/>
  <result pre="and rabbits, may be suitable as potential hosts for HBV" exact="infection" post="after hNTCP complementation. Culture and hNTCP complementation of PPHs"/>
  <result pre="the human cell line Huh7D exhibits increased susceptibility to HBV" exact="infection" post="in the presence of hNTCP compared with the HepG2"/>
  <result pre="with the hNTCP-recombinant lentivirus. Cells were harvested 4 days post-lentiviral" exact="infection" post="to determine the hNTCP mRNA expression levels by qPCR"/>
  <result pre="These hNTCP-expressing cells were subsequently subjected to HBV infection. HBV" exact="infection" post="of primary hepatocytes HBV infection was performed using concentrated"/>
  <result pre="subjected to HBV infection. HBV infection of primary hepatocytes HBV" exact="infection" post="was performed using concentrated viral stocks prepared from HepAD38"/>
  <result pre="experimental period was limited to 7 days post-infection (dpi). Following" exact="infection" post="with HBV (MOI=1,000), all cell types without hNTCP exhibited"/>
  <result pre="3E, HBeAg secretion was positive and continuously increased during HBV" exact="infection" post="with purified HBV particles, indicating that hNTCP-complemented PPHs could"/>
  <result pre="cytotoxicity. Therefore, purification is essential for the establishment of HBV" exact="infection" post="using human serum as the viral source. Anti-HBV drugs"/>
  <result pre="nM (Fig. 4A-C), which matches the reported data regarding HBV" exact="infection" post="in the PHH model (23). Lamivudine, an inhibitor of"/>
  <result pre="IC50 of ~50 nM. The less effective inhibition of HBV" exact="infection" post="by lamivudine possibly occurred due to the failure of"/>
  <result pre="differentiation status is an important limiting factor in productive HBV" exact="infection" post="and replication. According to viral antigen secretion and cccDNA"/>
  <result pre="hNTCP-complemented PPHs may be a superior cell model for HBV" exact="infection" post="compared with the dedifferentiated human hepatoma cell line Huh7D"/>
  <result pre="complemented with hNTCP may be a superior model for HBV" exact="infection" post="compared with the dedifferentiated human hepatoma cell line. hNTCP"/>
  <result pre="hNTCP expression, thus causing PHHs to be resistant to HBV" exact="infection" post="(9). Therefore, hNTCP-complemented PPHs may be more susceptible to"/>
  <result pre="(9). Therefore, hNTCP-complemented PPHs may be more susceptible to HBV" exact="infection" post="compared with PHHs. However, hNTCP-complemented PPHs have certain limitations,"/>
  <result pre="HBV-related fundamental research and drug screening. The MOI for HBV" exact="infection" post="of PPHs using HepAD38 cells as viral source was"/>
  <result pre="serum are intact. Therefore, different MOI was used in HBV" exact="infection" post="with different viral sources, which has been suggested for"/>
  <result pre="different viral sources, which has been suggested for successful HBV" exact="infection" post="in our previous publications (8–10). Lempp et al (27)"/>
  <result pre="have reported that hNTCP is the limiting factor in HBV" exact="infection" post="in pig hepatocytes, which was also demonstrated in the"/>
  <result pre="hNTCP-complemented PPHs may be a valuable tool for investigating HBV" exact="infection" post="and antiviral drugs. The results also indicated that the"/>
  <result pre="human hepatitis B and D virusElife1e00049201210.7554/eLife.0004923150796 5HeWRenBMaoFJingZLiYLiuYPengBYanHQiYSunYet al.Hepatitis D virus" exact="infection" post="of mice expressing human sodium taurocholate co-transporting polypeptidePLoS Pathog11e1004840201510.1371/journal.ppat.100484025902143"/>
  <result pre="maintenance of human fetal hepatocytes and prolonged susceptibility to HBV" exact="infection" post="by co-culture with non-parenchymal cellsJ Virol Methods195185193201410.1016/j.jviromet.2013.10.01024134944 9ZhouMHuangYChengZZhaoFLiJZhiXTianXSunWHuKRevival, characterization,"/>
  <result pre="non-parenchymal cellsJ Virol Methods195185193201410.1016/j.jviromet.2013.10.01024134944 9ZhouMHuangYChengZZhaoFLiJZhiXTianXSunWHuKRevival, characterization, and hepatitis B virus" exact="infection" post="of cryopreserved human fetal hepatocytesJ Virol Methods2072937201410.1016/j.jviromet.2014.06.01524977316 10ZhouMZhaoKYaoYYuanYPeiRWangYChenJHuXZhouYChenXWuCProductive HBV"/>
  <result pre="infection of cryopreserved human fetal hepatocytesJ Virol Methods2072937201410.1016/j.jviromet.2014.06.01524977316 10ZhouMZhaoKYaoYYuanYPeiRWangYChenJHuXZhouYChenXWuCProductive HBV" exact="infection" post="of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cellsVirol Sin32465475201710.1007/s12250-017-3983-x28971350 11LadnerSKOttoMJBarkerCSZaifertKWangGHGuoJTSeegerCKingRWInducible"/>
  <result pre="(HBV) in stably transfected hepatoblastoma cells: A novel system for" exact="screening" post="potential inhibitors of HBV replicationAntimicrob Agents Chemother4117151720199710.1128/AAC.41.8.17159257747 12KöckJNassalMMacNellySBaumertTFBlumHEvon WeizsäckerFEfficient"/>
  <result pre="screening potential inhibitors of HBV replicationAntimicrob Agents Chemother4117151720199710.1128/AAC.41.8.17159257747 12KöckJNassalMMacNellySBaumertTFBlumHEvon WeizsäckerFEfficient" exact="infection" post="of primary tupaia hepatocytes with purified human and woolly"/>
  <result pre="is regulated in a virus specific mannerPLoS Pathog6e1001082201010.1371/journal.ppat.100108220824087 14GlebeDAliakbariMKrassPKnoopEVValeriusKPGerlichWHPre-s1 antigen-dependent" exact="infection" post="of Tupaia hepatocyte cultures with human hepatitis B virusJ"/>
  <result pre="Xue Bao211811841990(In Chinese)2391101 23YeXZhouMHeYWanYBaiWTaoSRenYZhangXXuJLiuJet al.Efficient inhibition of hepatitis B virus" exact="infection" post="by a preS1-binding peptideSci Rep629391201610.1038/srep2939127384014 24GlebeDUrbanSKnoopEVCagNKrassPGrünSBulavaiteASasnauskasKGerlichWHMapping of the hepatitis"/>
  <result pre="polypeptide is the limiting host factor of Hepatitis B Virus" exact="infection" post="in macaque and pig hepatocytesHepatology66703716201710.1002/hep.2911228195359 Figure 1. Evolutionary distance"/>
  <result pre="hepatocyte maintenance medium; FBS, fetal bovine serum. Figure 3. HBV" exact="infection" post="of hNTCP-complemented hepatocytes. (A-C) Cells were infected with HBV"/>
  <result pre="media were collected at 3, 5 and 7 dpi for" exact="detection" post="of (A) HBeAg and (B) HBsAg by ELISA, and"/>
 </snippets>
</snippetsTree>
